Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Response to 'On Complicity and Compromise' by Chiara Lepora and Robert Goodin.

Calain P.

J Med Ethics. 2017 Apr;43(4):266. doi: 10.1136/medethics-2016-103397. Epub 2016 Sep 26. No abstract available.

PMID:
27670810
2.

The Ebola clinical trials: a precedent for research ethics in disasters.

Calain P.

J Med Ethics. 2018 Jan;44(1):3-8. doi: 10.1136/medethics-2016-103474. Epub 2016 Aug 29.

3.

Defective interfering genomes and Ebola virus persistence.

Calain P, Roux L, Kolakofsky D.

Lancet. 2016 Aug 13;388(10045):659-60. doi: 10.1016/S0140-6736(16)31272-7. No abstract available.

PMID:
27533436
4.

Counterterrorism policies and practices: health and values at stake.

Eckenwiler L, Hunt M, Ahmad A, Calain P, Dawson A, Goodin R, Messelken D, Rubenstein L, Wild V.

Bull World Health Organ. 2015 Oct 1;93(10):737-738. Epub 2015 Aug 31. No abstract available.

5.

Reaching out to Ebola victims: Coercion, persuasion or an appeal for self-sacrifice?

Calain P, Poncin M.

Soc Sci Med. 2015 Dec;147:126-33. doi: 10.1016/j.socscimed.2015.10.063. Epub 2015 Nov 9.

6.

Coincident polio and Ebola crises expose similar fault lines in the current global health regime.

Calain P, Abu Sa'Da C.

Confl Health. 2015 Sep 16;9:29. doi: 10.1186/s13031-015-0058-1. eCollection 2015.

7.

What is the relationship of medical humanitarian organisations with mining and other extractive industries?

Calain P.

PLoS Med. 2012;9(8):e1001302. doi: 10.1371/journal.pmed.1001302. Epub 2012 Aug 28.

8.

Ethics and images of suffering bodies in humanitarian medicine.

Calain P.

Soc Sci Med. 2013 Dec;98:278-85. doi: 10.1016/j.socscimed.2012.06.027. Epub 2012 Jul 27.

9.

In Search of the 'New Informal Legitimacy' of Médecins Sans Frontières.

Calain P.

Public Health Ethics. 2012 Apr;5(1):56-66. Epub 2011 Dec 30.

10.

High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009-2010.

Sanchez-Padilla E, Dlamini T, Ascorra A, Rüsch-Gerdes S, Tefera ZD, Calain P, de la Tour R, Jochims F, Richter E, Bonnet M.

Emerg Infect Dis. 2012 Jan;18(1):29-37. doi: 10.3201/eid1801.110850.

11.

Oil for health in sub-Saharan Africa: health systems in a 'resource curse' environment.

Calain P.

Global Health. 2008 Oct 21;4:10. doi: 10.1186/1744-8603-4-10.

12.
13.

Exploring the international arena of global public health surveillance.

Calain P.

Health Policy Plan. 2007 Jan;22(1):2-12.

PMID:
17237489
14.

Can oral cholera vaccination play a role in controlling a cholera outbreak?

Calain P, Chaine JP, Johnson E, Hawley ML, O'Leary MJ, Oshitani H, Chaignat CL.

Vaccine. 2004 Jun 23;22(19):2444-51. Review.

PMID:
15193408
15.

Ebola virus defective interfering particles and persistent infection.

Calain P, Monroe MC, Nichol ST.

Virology. 1999 Sep 15;262(1):114-28.

16.

Long-term disease surveillance in Bandundu region, Democratic Republic of the Congo: a model for early detection and prevention of Ebola hemorrhagic fever.

Lloyd ES, Zaki SR, Rollin PE, Tshioko K, Bwaka MA, Ksiazek TG, Calain P, Shieh WJ, Kondé MK, Verchueren E, Perry HN, Manguindula L, Kabwau J, Ndambi R, Peters CJ.

J Infect Dis. 1999 Feb;179 Suppl 1:S274-80.

PMID:
9988195
17.

Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995.

Guimard Y, Bwaka MA, Colebunders R, Calain P, Massamba M, De Roo A, Mupapa KD, Kibadi K, Kuvula KJ, Ndaberey DE, Katwiki KR, Mapanda BB, Nkuku OB, Fleerackers Y, Van den Enden E, Kipasa MA.

J Infect Dis. 1999 Feb;179 Suppl 1:S268-73.

PMID:
9988194
18.

A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidémies à Kikwit.

Zaki SR, Shieh WJ, Greer PW, Goldsmith CS, Ferebee T, Katshitshi J, Tshioko FK, Bwaka MA, Swanepoel R, Calain P, Khan AS, Lloyd E, Rollin PE, Ksiazek TG, Peters CJ.

J Infect Dis. 1999 Feb;179 Suppl 1:S36-47.

PMID:
9988163
19.

Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients.

Bwaka MA, Bonnet MJ, Calain P, Colebunders R, De Roo A, Guimard Y, Katwiki KR, Kibadi K, Kipasa MA, Kuvula KJ, Mapanda BB, Massamba M, Mupapa KD, Muyembe-Tamfum JJ, Ndaberey E, Peters CJ, Rollin PE, Van den Enden E, Van den Enden E.

J Infect Dis. 1999 Feb;179 Suppl 1:S1-7.

PMID:
9988155
20.
21.
23.

Molecular cloning of natural paramyxovirus copy-back defective interfering RNAs and their expression from DNA.

Calain P, Curran J, Kolakofsky D, Roux L.

Virology. 1992 Nov;191(1):62-71.

PMID:
1329337
24.
25.

Clinical efficacy of teicoplanin.

Calain P, Waldvogel F.

Eur J Clin Microbiol Infect Dis. 1990 Feb;9(2):127-9. No abstract available.

PMID:
2138542
26.

Serological study of meningococcal isolates in Switzerland and France 1980-1986.

Calain P, Poolman J, Zollinger W, Sperber G, Bitter-Suermann D, Auckenthaler R, Hirschel B.

Eur J Clin Microbiol Infect Dis. 1988 Dec;7(6):788-91.

PMID:
3145866
28.

[Cytomegalovirus infections following transplantation: diagnosis, prevention and treatment].

Calain P, Lew D.

Rev Med Suisse Romande. 1988 Aug;108(8):697-701. French. No abstract available.

PMID:
2847275
29.

Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections.

Calain P, Krause KH, Vaudaux P, Auckenthaler R, Lew D, Waldvogel F, Hirschel B.

J Infect Dis. 1987 Feb;155(2):187-91.

PMID:
2949024

Supplemental Content

Loading ...
Support Center